Omeros Corporation

0.00 (0.00%)
Debt Financing / Related, Products, Divestitures / Spin-offs

Omeros Announces Agreement To Sell Omidria® Franchise To Rayner Surgical In A Transaction Valued In Excess Of $1 Billion

Published: 12/02/2021 13:08 GMT
Omeros Corporation (OMER) - Press Release - Omeros Announces Agreement to Sell Omidria® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion.
Omeros Corp - Deal for $125 Million Upfront Payment and $200 Million on Achievement of Commercial Milestone.
Omeros Corp - Deal Includes Royalties of 50% on U.S. Net Sales Until Earlier of Either January 1, 2025 Or Payment of $200-million Milestone.
Omeros Corp - Omidria to Become a Premier Product in Rayner's Ophthalmology Franchise.
Omeros Corp - Together With Substantial Royalties to Be Paid by Rayner to Omeros on Net Sales of Omidria, Transaction is Valued in Excess of $1 Billion.